- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
Anonymous complaint alleged Allergan engineered a training meeting, selected delegates and bypassed slide approval. Panel found no supporting evidence and accepted Allergan’s…
Complaint alleged Shire failed to disclose Resolor (prucalopride) clinical trial results per ABPI requirements. Panel found older trials pre-dated disclosure obligations and…
A GP complained about an unsolicited promotional email about Crestor sent to an NHS email address via an agency. The Panel ruled…
Bayer challenged Lixiana leavepiece claims. Panel found breaches where VTE “initiation” wording obscured heparin lead-in and where a 30‑day pill-burden graph was…
Anonymous complaint about emails, training, joint MA/MSL calls and call-rate targets. No breaches for emails/training/joint calls, but breach found for unclear call/contact…
Anonymous complaint alleged pressure on reps via cycle plans and CRM logging, plus GP-PEP speaker governance issues. Breaches found for unclear call/contact…
Complaint that Lilly’s oncology handbook was out of date and misleading for omitting newer cancer medicines. Panel found publication date/disclaimer were clear…
HCP website described theiCal-D3 and Stirlescent as ‘new’. Panel found theiCal-D3 had been on market >12 months so breach of Clause 7.11;…
Anonymous oncologist alleged overly frequent contact, unannounced clinic visits, old data and failure to leave copies. Panel found allegations unproven (no supporting…
Ex-rep alleged pressure to drive Seretide-to-Flutiform switches, misleading cost-savings, data protection risks, and improper use of therapy review services/meetings. Panel found no…
Complaint alleged a patient on stage during a Tivicay-focused webinar amounted to promotion to the public and that prescribing information wasn’t one-click…
BMJ website ad for Migard (frovatriptan) used an out-of-date SPC link and omitted required prescribing information elements (incl. legal classification and cost).…
A PCT chief pharmacist challenged Takeda’s PROactive study messaging in a DHP letter for Actos/Competact. The Panel found the primary endpoint was…
A Cymbalta detail aid implied duloxetine and venlafaxine XL had equivalent efficacy based on a single head-to-head study. The Panel found the…
Lilly self-reported a meeting dinner with overseas psychiatry associations. Two attendees were spouses and not qualifying delegates. Panel found hospitality non-compliant and…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.